Skip to main content
CSTM
NYSE Manufacturing

Constellium Reports Record Q4 & Strong FY25 Results, Exceeding Expectations with Robust Free Cash Flow and Shareholder Returns; Provides Positive 2026 Guidance

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$24.46
Mkt Cap
$3.226B
52W Low
$7.325
52W High
$25.49
Market data snapshot near publication time

summarizeSummary

Constellium SE announced record fourth-quarter and strong full-year 2025 financial results, driven by increased shipments and improved profitability, alongside robust free cash flow generation and significant share repurchases. The company also provided positive guidance for 2026 and outlined ambitious 2028 targets.


check_boxKey Events

  • Record Q4 and Strong FY25 Financial Performance

    Constellium reported a record fourth-quarter Adjusted EBITDA of $280 million, a 124% increase year-over-year, and full-year 2025 Adjusted EBITDA of $846 million, up 36%. Net income for Q4 2025 was $113 million (vs. a $47 million net loss in Q4 2024), and full-year net income was $275 million (vs. $60 million in 2024).

  • Robust Free Cash Flow Generation

    The company generated $110 million in Free Cash Flow for Q4 2025 and $178 million for the full year 2025, a significant improvement from a negative $100 million in 2024. This was driven by higher Segment Adjusted EBITDA and lower capital expenditures.

  • Significant Shareholder Returns and Debt Reduction

    Constellium repurchased 8.9 million shares for $115 million during 2025, demonstrating a strong commitment to returning capital to shareholders. Leverage was reduced to 2.5x at year-end 2025, within the target range.

  • Positive 2026 Guidance and 2028 Targets

    For 2026, the company expects Adjusted EBITDA (excluding metal price lag) to be in the range of $780 million to $820 million and Free Cash Flow in excess of $200 million. Long-term targets for 2028 include Adjusted EBITDA of $900 million and Free Cash Flow of $300 million.


auto_awesomeAnalysis

Constellium SE delivered a strong financial performance for both the fourth quarter and full year 2025, surpassing expectations with record Q4 Adjusted EBITDA and significant improvements in net income and free cash flow. The company's strategic focus on operational excellence, including the new 'Vision 2028' program, underpins its optimistic 2026 guidance and long-term targets. The substantial share repurchase program in 2025 demonstrates a commitment to shareholder returns. This positive news, coupled with the stock trading near its 52-week high, suggests continued investor confidence in the company's trajectory and its ability to navigate market dynamics while driving profitability and cash generation.

At the time of this filing, CSTM was trading at $24.46 on NYSE in the Manufacturing sector, with a market capitalization of approximately $3.2B. The 52-week trading range was $7.33 to $25.49. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CSTM - Latest Insights

CSTM
Apr 29, 2026, 1:10 PM EDT
Filing Type: 10-Q
Importance Score:
8
CSTM
Apr 29, 2026, 6:09 AM EDT
Source: Reuters
Importance Score:
9
CSTM
Apr 29, 2026, 6:07 AM EDT
Filing Type: 8-K
Importance Score:
9
CSTM
Apr 21, 2026, 6:01 AM EDT
Source: Reuters
Importance Score:
8
CSTM
Apr 10, 2026, 8:37 AM EDT
Filing Type: DEFA14A
Importance Score:
7
CSTM
Apr 10, 2026, 8:34 AM EDT
Filing Type: DEF 14A
Importance Score:
7
CSTM
Mar 30, 2026, 9:24 AM EDT
Filing Type: PRE 14A
Importance Score:
8
CSTM
Mar 12, 2026, 5:04 PM EDT
Filing Type: 8-K
Importance Score:
8
CSTM
Mar 12, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
CSTM
Feb 25, 2026, 4:40 PM EST
Filing Type: 10-K
Importance Score:
8